Medical Science Liaison, Northeast

Adaptive Biotechnologies
Job Location
Field Based
New York, NY 10001

Salary is commensurate with experience and qualifications. Excellent benefits package including employer paid medical, dental, vision, vacations and holidays for eligible positions.

Adaptive Biotechnologies Corp. is proud to be an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.

NOTE TO EMPLOYMENT AGENCIES: Adaptive Biotechnologies values our relationships with our Recruitment Partners and will only accept resumes from those partners whom have been contracted by a member of our Human Resources team to collaborate with us. Adaptive Biotechnologies is not responsible for any fees related to resumes that are unsolicited or are received by any employee of Adaptive Biotechnologies who is not a member of the Human Resources team.

Job Description

Position Overview:

Medical Science Liaisons are responsible for developing and expanding the clinical community’s knowledge of the role for Minimal Residual Disease (MRD) in the management of lymphoid malignancies by educating and informing physicians about the clonoSEQ Assay. Our MSL team will provide up-to-date medical information to local, regional and national thought leaders related to use of the clonoSEQ Assay in hematological malignancies as well as the scientific advantage of NGS based MRD assessment. The MSL role also includes: developing creative and innovative tactics for addressing the specific needs of key customers; coordinate and manage regional investigator trials; represent real time voice of customer input related product development opportunities; conduct clinical presentations to payer organizations and patient advocacy groups.

Note: This role will cover the Northeast US territory and may reside in New York, New Jersey, Boston, Philadelphia, or other surrounding cities.


Job Responsibilities:

  • Develop and maintain significant scientific relationships with hematology Key Opinion Leaders
  • Present scientific information to various groups
  • Provide internal teams with feedback and insights from interactions and discussions with HCPs
  • Coordinate local and regional investigator initiated research (IIR)
  • Manage IIR milestones and objectives
  • Report on scientific sessions at congresses
  • Respond to and document unsolicited requests for scientific information
  • Provide clinical input and assist with training to internal functions as requested
  • Provide Advisory Board content development support
  • Work closely with other field based teams and HQ staff to respond to information requests in a timely manner

Required Experience:

  • MD, PharmD, or PhD
  • 3-5 years industry and clinical hematology/oncology experience
  • Existing relationships with NCI institution
  • Demonstrated understanding of cooperative groups clinical trial management
  • Previous medical device/pharmaceutical industry experience preferred
  • Working knowledge of regulatory guidance and reporting requirements
  • Exceptional organizational and time management skills
  • Strong presentations skills including excellent verbal and written communication
  • Computer proficiency in Excel, Word, PowerPoint and Adobe®
  • Travel frequently (40-70%)
About Our Organization

ARE YOU ADAPTIVE? We’re driving groundbreaking research in cancer and other immune-mediated diseases that translates into novel clinical diagnostics and innovative therapeutics. We are at the forefront of immune-based discoveries, transforming the future state of health through our disruptive, proprietary immunosequencing technology. With strong financial footing and rapid growth, we are looking for the brightest, most passionate and collaborative innovators to join us.

At Adaptive, you'll be challenged, you'll be inspired, and you'll be proud to be part of an innovative organization making a real impact on improving the quality of life globally. No matter what your role is, you'll find a diverse, team-driven, fun culture where your contributions truly count. #BeingAdaptive


About the clonoSEQ Assay

When it comes to treating blood cancers, a physician’s ability to detect minute traces of disease is critical to patient care. The clonoSEQ Assay is up to 100 times more sensitive than other leading minimal residual disease (MRD) detection methods. clonoSEQ MRD results allow a physician to adjust treatment based on disease burden, assess response to therapy over time, and monitor patients while in remission. Based on a physician’s judgment, these results may mean the possibility of earlier intervention or less unnecessary treatment.

An analysis appearing in PeerJ finds that social media mentions of a paper may lead to increased citations.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.